BioSpace News Archive

FDA clearance makes clinically validated assay available for sexually-transmitted infection listed as emerging threat by the CDC

Torchmark Corporation (NYSE: TMK) will release Fourth Quarter 2018 earnings after the market closes on Tuesday, February 5, 2019.

Jan. 24, 2019 03:16 UTC NEW YORK--( BUSINESS WIRE )-- UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on uro-oncology, today announced the pricing of its public offering of 3,658,537 ordinary shares at a public offering price of $41.00 per share, for a total public offering size of approximately $150.0 million, befo

Nearly everyone can relate to the mission of St. Jude Children’s Research Hospital: Finding cures, Saving children®.

Topix Pharmaceuticals, the leading independent provider of premium, custom and branded skincare, today announced the creation of several key new leadership roles.

Institute for Protein Innovation Head of Protein Design to present at TED2019, joining the newest class of 20 global visionaries.

The Lustgarten Foundation announced today the opening of its fourth dedicated pancreatic cancer research laboratory at Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, Maryland.

Ergomed plc (LSE: ERGO) (“Ergomed” or the “Company”), a company focused on providing specialised services to the pharmaceutical industry, announces Board and management changes.

The Scientific Center for Optical and Electron Microscopy (ScopeM) is a central scientific technology platform of ETH Zurich providing resources and services in light and electron microscopy as well as direct access to state-of-the-art microscopy and sample preparation equipment.

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced the launch of services for new biological entities, called NBE Product Characterization